by Jordana Choucair | Aug 29, 2022 | Life Sciences
The federal government announced it no longer supply free at-home COVID-19 tests via the U.S. Postal Service effective Friday, September 2. The announcement, posted to the federal government’s COVID-19 website, said that the program is being suspended because...
by Jordana Choucair | Aug 29, 2022 | Life Sciences
Moderna filed a lawsuit against Pfizer and BioNTech, alleging the vaccine makers “unlawfully copied Moderna’s inventions, and they have continued to use them without permission.” Moderna is seeking compensation from Pfizer for the use of technology that it says it...
by Jordana Choucair | Aug 26, 2022 | Life Sciences
Pfizer Inc. said its vaccine to protect older adults against the respiratory syncytial virus (RSV) effectively reduced severe cases of the illness by nearly 86 percent. The drugmaker, which views the RSVpreF vaccine as a critical offering in its lineup of experimental...
by Jordana Choucair | Aug 26, 2022 | Life Sciences
The White House released a policy guidance requiring academic journals to provide access to papers that are publicly funded. The policy would end an optional 12-month publication embargo allowing journals to put work behind a yearlong paywall. The Office of Science...
by Jordana Choucair | Aug 25, 2022 | Life Sciences
Democratic lawmakers on the House Select Subcommittee on the Coronavirus Crisis released a report indicating that senior Trump administration officials leaned on Food and Drug Administration (FDA) Commissioner Stephen Hahn and other agency leaders to sign off on...
by Jordana Choucair | Aug 25, 2022 | Life Sciences
A large Israeli study found that Pfizer Inc.’s COVID-19 treatment Paxlovid lowered hospitalization rates in 65-year-olds and older by about 75 percent. However, people ages 40-64 who took the drug shortly after infection saw little to no benefit. The study was...
Recent Comments